Enabling One Health through Bio-Innovation
Research & Development
Strategic Advisory & Tech Consulting
In & Out Licensing
Contract Development & Manufacturing
HORIZON
High-impact One-health Research & Innovation ZONe
A GMP-like facility thoughtfully designed with innovative and sustainable concepts, aimed at enabling efficient and environmentally responsible production of preclinical vaccine batches.
GCMC
Global Collaborative Centre for Medical Countermeasures
An EU-GMP-compliant facility purpose-built to enable seamless scale-up and accelerate the translation of vaccine candidates from the pre-clinical stage through clinical development to full-scale commercialization.
This continuum enables TechInvention to support LMIC-focused innovation with speed, efficiency, and quality.
Antimicrobial resistance (AMR) continues to severely affect global health and the global economy. It is one of the most serious public health threats of the 21st century, exacerbated by antibiotic overuse and misuse worldwide.It is responsible for 700,000 deaths annually and is predicted to cause more than 10 million deaths by 2050. It is essential to take the One Health approach to effectively address the AMR issue. The concept of One Health refers to an all-encompassing strategy for improving the well-being of people, animals, and the environment.
To enable and support One Health, TechInvention employs four strategies: research and development, contract development and manufacturing for scale-ups and commercial production, technical and strategic advisory for capacity building, and global access to diagnostics, vaccines, and biopharmaceuticals.
Regulatory Status of In-licensed Products
Global Project & Partners
